{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:55:26Z","timestamp":1763758526331,"version":"3.45.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.otc.2025.08.020","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:06:15Z","timestamp":1759521975000},"page":"77-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision Radiotherapy for HPV-Associated Oropharyngeal Carcinoma"],"prefix":"10.1016","volume":"59","author":[{"given":"Colin","family":"Faulkner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Stutheit-Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nauman","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.otc.2025.08.020_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241288251","article-title":"Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials","volume":"17","author":"Gurizzan","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.otc.2025.08.020_bib3","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hed.26638","article-title":"Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy","volume":"43","author":"Greco","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.otc.2025.08.020_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamaoto.2013.4072","article-title":"Depression among long-term survivors of head and neck cancer treated with radiation therapy","volume":"139","author":"Chen","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2025.08.020_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.micinf.2017.06.001","article-title":"Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer","volume":"19","author":"Faraji","year":"2017","journal-title":"Microbes Infect"},{"key":"10.1016\/j.otc.2025.08.020_bib6","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1002\/lary.28083","article-title":"Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer","volume":"130","author":"White","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2025.08.020_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2015.08.033","article-title":"Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus\u2013Associated Oropharyngeal Squamous Cell Carcinoma","volume":"93","author":"Chera","year":"2015","journal-title":"Int J Radiat Oncol\u2217Biol\u2217Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib8","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of DE-intensified chemoradiotherapy for human Papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.otc.2025.08.020_bib10","first-page":"1","article-title":"Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2020.01.016","article-title":"Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel\/cisplatin to standard radiotherapy with fluorouracil\/cisplatin: The PacCis-trial","volume":"144","author":"Fietkau","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: Phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib13","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2024.08.014","article-title":"Interim Futility Results of NRG-HN005, A Randomized, Phase II\/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients","volume":"120","author":"Yom","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.otc.2025.08.020_bib14","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1200\/JCO.2022.40.16_suppl.6075","article-title":"Nivolumab-based induction chemoimmunotherapy and PD-L1 expression in locoregionally advanced HPV-associated oropharyngeal squamous cell carcinoma","volume":"40","author":"Rosenberg","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.otc.2025.08.020_bib15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.23.01308","article-title":"Hypoxia-directed treatment of human papillomavirus\u2013related oropharyngeal carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.otc.2025.08.020_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2020.01.005","article-title":"Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome","volume":"143","author":"Deschuymer","year":"2020","journal-title":"Radiotherapy and Oncology"},{"issue":"4","key":"10.1016\/j.otc.2025.08.020_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.prro.2016.11.002","article-title":"Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"7","author":"Leeman","year":"2017","journal-title":"Practical Radiation Oncology"},{"key":"10.1016\/j.otc.2025.08.020_bib18","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/cncr.28938","article-title":"Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life","volume":"120","author":"Spencer","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.otc.2025.08.020_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijrobp.2015.12.380","article-title":"Elective nodal irradiation and patterns of failure in head and neck cancer after primary radiation therapy","volume":"94","author":"Kjems","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.prro.2024.05.007","article-title":"Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline","volume":"14","author":"Margalit","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaoncol.2021.6416","article-title":"Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus-associated oropharyngeal carcinoma treated with definitive Chemoradiotherapy","volume":"8","author":"Tsai","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib22","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1200\/JCO-24-02194","article-title":"Clinical benefit and safety of reduced elective dose in definitive radiotherapy for head and neck squamous cell carcinoma: the UPGRADE-RT Multicenter Randomized Controlled Trial","volume":"43","author":"Sven van den Bosch","year":"2025","journal-title":"JCO"},{"key":"10.1016\/j.otc.2025.08.020_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijrobp.2017.01.018","article-title":"Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later","volume":"98","author":"Huang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2012.12.006","article-title":"Unilateral neck irradiation for well-lateralized oropharyngeal cancer","volume":"106","author":"Al-Mamgani","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib32","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.ijrobp.2024.01.032","article-title":"Early Outcomes for A Single-Arm Phase I\/II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral N0 Neck of Patients with p16-Positive Oropharynx Cancer","volume":"118","author":"Molitoris","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.otc.2025.08.020_bib33","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijrobp.2024.08.022","article-title":"A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma","volume":"120","author":"Bratman","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.otc.2025.08.020_bib35","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat. Commun"},{"key":"10.1016\/j.otc.2025.08.020_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2024.07.1702","article-title":"Relationship between elective neck irradiation and severe lymphopenia in patients treated with head and neck chemoradiotherapy","volume":"120","author":"Mickel","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110373","article-title":"De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: Who, why, what, where, when, how, how much, and what next?","volume":"200","author":"Chen","year":"2024","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.otc.2025.08.020_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.02.017","article-title":"Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer","volume":"78","author":"Saarilahti","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/COC.0000000000000064","article-title":"Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes","volume":"38","author":"Tam","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hed.23924","article-title":"Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance","volume":"38","author":"Mohindra","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.otc.2025.08.020_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2020.09.063","article-title":"Prospective phase 2 study of radiation therapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer","volume":"109","author":"Sher","year":"2021","journal-title":"Int J Radiat Oncol\u2217Biol\u2217Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib29","article-title":"Dosimetric and radiobiological analyses of a de-escalation strategy for elective nodal regions in human papillomavirus-associated oropharyngeal cancer","volume":"28","author":"Tomita","year":"2023","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib30","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1158\/1078-0432.CCR-23-0334","article-title":"Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial","volume":"29","author":"Sher","year":"2023","journal-title":"Clin Can Res"},{"key":"10.1016\/j.otc.2025.08.020_bib31","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.ijrobp.2024.01.063","article-title":"ENID: Phase II Trial of Definitive Chemoradiation with Elective Nodal Irradiation Dose De-Escalation for P16 Positive Squamous Cell Carcinoma of the Oropharynx","volume":"118","author":"Biedermann","year":"2024","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.1016\/j.otc.2025.08.020_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"The lancet oncology"},{"issue":"4","key":"10.1016\/j.otc.2025.08.020_bib39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2012.08.004","article-title":"Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy","volume":"85","author":"Garden","year":"2013","journal-title":"International Journal of Radiation Oncology\u2217 Biology\u2217 Physics"},{"key":"10.1016\/j.otc.2025.08.020_bib40","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00405-018-5050-0","article-title":"SPECT\/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma","volume":"275","author":"de Veij Mestdagh","year":"2018","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"key":"10.1016\/j.otc.2025.08.020_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6331-8","article-title":"Mapping of sentinel lymph node drainage using SPECT\/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial","volume":"19","author":"de Veij Mestdagh","year":"2019","journal-title":"BMC cancer"},{"key":"10.1016\/j.otc.2025.08.020_bib42","doi-asserted-by":"crossref","unstructured":"De Almeida JR, Parulekar WR, Christopoulos A, et al. CCTG HN11: SPECT-CT guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer\u2014A phase III randomized controlled trial. 2023. Meeting Abstract: 2023 ASCO Annual Meeting.","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS6114"},{"key":"10.1016\/j.otc.2025.08.020_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.otc.2025.08.020_bib44","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3390\/cancers14123027","article-title":"Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer","volume":"14","author":"Ridder","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.otc.2025.08.020_bib45","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.adro.2019.06.001","article-title":"Does 5+ 5 equal better radiation treatment plans in head and neck cancers?","volume":"4","author":"Corkum","year":"2019","journal-title":"Advances in Radiation Oncology"},{"key":"10.1016\/j.otc.2025.08.020_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.clon.2021.07.009","article-title":"Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study","volume":"33","author":"Vreugdenhil","year":"2021","journal-title":"Clinical Oncology"},{"journal-title":"Int J Radiat Oncol Biol Phys","year":"2024","author":"Guo","key":"10.1016\/j.otc.2025.08.020_bib47"},{"key":"10.1016\/j.otc.2025.08.020_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.radonc.2021.07.016","article-title":"Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes","volume":"162","author":"Al-Mamgani","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2018.06.032","article-title":"The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)","volume":"130","author":"Navran","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib50","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.ijrobp.2023.08.032","article-title":"Acute toxicity and efficiency outcomes in the DARTBOARD randomized trial of daily adaptive radiotherapy for head and neck squamous cell carcinoma","volume":"117","author":"Sher","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110178","article-title":"In silico evaluation and feasibility of near margin-less head and neck daily adaptive radiotherapy","volume":"197","author":"Dohopolski","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.otc.2025.08.020_bib52","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.ijrobp.2024.07.382","article-title":"Dosimetric evaluation of PTV margin reduction for online adaptive radiotherapy in head and neck cancer sequential boost treatments","volume":"120","author":"Nasser","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.otc.2025.08.020_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104373","article-title":"Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification","volume":"86","author":"Zeng","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.otc.2025.08.020_bib54","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-19-0211","article-title":"Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer","volume":"25","author":"Chera","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.otc.2025.08.020_bib55","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-23-1478","article-title":"Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance","volume":"29","author":"Hanna","year":"2023","journal-title":"Clinical Cancer Research"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666525001240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666525001240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:51:54Z","timestamp":1763758314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666525001240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0030666525001240"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2025.08.020","relation":{},"ISSN":["0030-6665"],"issn-type":[{"type":"print","value":"0030-6665"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision Radiotherapy for HPV-Associated Oropharyngeal Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2025.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}